Doxorubicin treatment in vivo causes cytochrome C release and cardiomyocyte apoptosis, as well as increased mitochondrial efficiency, superoxide dismutase activity, and Bcl-2:Bax ratio. (Q51706854)
Jump to navigation
Jump to search
scientific article published in August 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Doxorubicin treatment in vivo causes cytochrome C release and cardiomyocyte apoptosis, as well as increased mitochondrial efficiency, superoxide dismutase activity, and Bcl-2:Bax ratio. |
scientific article published in August 2002 |
Statements
Doxorubicin treatment in vivo causes cytochrome C release and cardiomyocyte apoptosis, as well as increased mitochondrial efficiency, superoxide dismutase activity, and Bcl-2:Bax ratio (English)
Christiaan Leeuwenburgh
April C Childs
Sharon L Phaneuf
Amie J Dirks
Tracey Phillips
1 August 2002